Sanford C. Bernstein Forecasts Strong Price Appreciation for agilon health (NYSE:AGL) Stock

agilon health (NYSE:AGL) had its price objective boosted by Sanford C. Bernstein from $2.50 to $3.15 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage currently has a “market perform” rating on the stock. Sanford C. Bernstein’s target price would indicate a potential upside of 6.24% from the stock’s previous close.

Several other equities research analysts have also issued reports on the stock. Evercore ISI lowered their price target on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a report on Tuesday, October 8th. JMP Securities lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday, November 11th. Needham & Company LLC started coverage on agilon health in a report on Friday, January 10th. They set a “hold” rating on the stock. Stifel Nicolaus dropped their target price on agilon health from $7.00 to $2.00 and set a “hold” rating for the company in a report on Tuesday, November 12th. Finally, William Blair lowered agilon health from an “outperform” rating to a “market perform” rating in a research note on Friday, November 8th. Two equities research analysts have rated the stock with a sell rating, fourteen have given a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $4.03.

agilon health Stock Up 5.1 %

NYSE AGL opened at $2.97 on Wednesday. agilon health has a twelve month low of $1.50 and a twelve month high of $7.73. The stock has a market cap of $1.22 billion, a PE ratio of -3.15 and a beta of 0.53. The firm has a 50-day simple moving average of $2.07 and a 200 day simple moving average of $3.67. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29.

agilon health (NYSE:AGL) last announced its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The firm had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same quarter in the prior year, the business posted ($0.06) EPS. On average, research analysts forecast that agilon health will post -0.59 EPS for the current year.

Insider Transactions at agilon health

In other news, Director John William Wulf purchased 45,000 shares of the business’s stock in a transaction dated Thursday, December 5th. The shares were acquired at an average price of $2.18 per share, with a total value of $98,100.00. Following the completion of the purchase, the director now directly owns 206,133 shares of the company’s stock, valued at $449,369.94. The trade was a 27.93 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Karen Mcloughlin acquired 25,000 shares of the stock in a transaction that occurred on Friday, December 13th. The stock was purchased at an average price of $2.20 per share, with a total value of $55,000.00. Following the completion of the transaction, the director now owns 73,166 shares of the company’s stock, valued at approximately $160,965.20. This trade represents a 51.90 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have purchased 90,000 shares of company stock worth $198,100. Corporate insiders own 3.20% of the company’s stock.

Institutional Investors Weigh In On agilon health

A number of institutional investors and hedge funds have recently modified their holdings of AGL. Oak Thistle LLC acquired a new stake in agilon health during the 4th quarter worth $25,000. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of agilon health during the third quarter worth $28,000. Pines Wealth Management LLC bought a new stake in agilon health in the fourth quarter valued at about $51,000. City State Bank acquired a new position in agilon health in the third quarter valued at about $52,000. Finally, Aigen Investment Management LP bought a new position in agilon health during the third quarter worth about $79,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.